Metraipolis › archive › dc_2c265e7ae40c
Case Report: Neuroretinitis following combination checkpoint inhibition therapy with nivolumab and ipilimumab for stage IIIC melanoma — Europe PMC PMID:42756432
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42756432
- DOI
- 10.3389/fonc.2026.1872343
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T05:09:13.435Z
- SHA-256 of the archived text
7f6e541eba50e87ad484a62737b79cc2aad55afebe7b24d42412e6141dbf73ff- Stable URL of this page
https://metraipolis.com/documento/dc_2c265e7ae40c
How to cite
Case Report: Neuroretinitis following combination checkpoint inhibition therapy with nivolumab and ipilimumab for stage IIIC melanoma — Europe PMC PMID:42756432 — Europe PMC (en), https://europepmc.org/article/MED/42756432 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c265e7ae40c (Metraipolis archive dc_2c265e7ae40c, sha256 7f6e541eba50e87ad484a62737b79cc2aad55afebe7b24d42412e6141dbf73ff)
BibTeX
@misc{dc2c265e7ae40c,
title = {Case Report: Neuroretinitis following combination checkpoint inhibition therapy with nivolumab and ipilimumab for stage IIIC melanoma — Europe PMC PMID:42756432},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42756432},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c265e7ae40c; sha256 7f6e541eba50e87ad484a62737b79cc2aad55afebe7b24d42412e6141dbf73ff},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42756432. Agents can read the archived copy with the MCP tool read_document.